Showing results (1361-1370 of 1,708) with videos related to
Sort By:
Pageof 171
Heart (British Cardiac Society)|June 18, 2025
Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mappingAsad Bhatty, Chris Wilkinson, Suleman Aktaa, et al.Journal of Clinical Medicine|September 9, 2023
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future DirectionsFrancesco Perone, Marco Bernardi, Alban Redheuil, et al.International Angiology : a Journal of the International Union of Angiology|November 30, 2019
Global perspective on carotid intima-media thickness and plaque: should the current measurement guidelines be revisited?Luca Saba, Ankush Jamthikar, Deep Gupta, et al.Circulation|December 1, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary SyndromeSotirios Tsimikas, Michael Szarek, Christa M Cobbaert, et al.Diabetes, Obesity & Metabolism|January 12, 2018
DECLARE-TIMI 58: Participants' baseline characteristicsItamar Raz, Ofri Mosenzon, Marc P Bonaca, et al.Lancet (London, England)|March 15, 2017
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsFrancesco Costa, David van Klaveren, Stefan James, et al.Journal of the American College of Cardiology|March 25, 2017
Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized TrialsEmily S Lau, Eugene Braunwald, Sabina A Murphy, et al.Cerebrovascular Diseases (Basel, Switzerland)|March 14, 2008
Risk factor profile and management of cerebrovascular patients in the REACH RegistryJoachim Röther, Mark J Alberts, Emmanuel Touzé, et al.European Heart Journal|March 7, 2023
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trialGregory G Schwartz, Michael Szarek, Deepak L Bhatt, et al.Diabetes Care|November 18, 2022
Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58Rena Pollack, Itamar Raz, Stephen D Wiviott, et al.Pageof 171